Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Unknown 2 Terminated 2 Completed 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Cyclophosphamide 22 fludarabine 17 Specimen Handling 13 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Nivolumab 9 Radiotherapy 7 Cisplatin 7 fludarabine phosphate 5 Injections 5 Doxorubicin 5 Biopsy 5 tislelizumab 4 daratumumab 4 Rituximab 4 Paclitaxel 4 Ipilimumab 4 Interleukin-2 4 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Fluorouracil 4 Drug Therapy 4 Dexamethasone 4 Carboplatin 4 venetoclax 3 toripalimab 3 ruxolitinib 3 X-Rays 3 Vincristine 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × Biological Products × Clear all

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡